HF  Viking Global Investors

https://www.vikingglobal.com/





     Office Locations:

55 Railroad Ave. #300
Greenwich, CT 06830
Phone: 203-863-5000

 

Stages:

  • Early
  • Middle Market


 

Industries:

  • Financial Services
  • Food & Agriculture
  • Life Sciences & Healthcare

  •  

    Description:

    Viking Global Investors LP is a global investment firm founded in 1999. The firm manages approximately $26 billion of capital for our investors. Viking has offices in Greenwich, New York, Hong Kong, London and San Francisco and is registered as an investment adviser with the U.S. Securities and Exchange Commission. The firm uses fundamental analysis to select investments, primarily public and private equity interests, across industries and geographies. Viking generally invests in companies based on a thorough assessment of their business models and fundamentals, the quality of their management teams and cyclical and secular industry trends.


     

    Funds:


      Fund Name


      Amount


      Date

    Get funds under management for this firm including Fund name, Dollar size of fund raise, and Vintage with a National Database subscription or New York Database subscription.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or New York Database subscription.
    David Truetzel Analyst
    Hans Reuter

     

    Recent Funding Events (trailing 12 months):


      Date


      Name


      State


      Amount


      Stage


      11/28/2018


      Auris Health


      CA


      $220,000,000


      


      10/03/2018


      Talkdesk


      CA


      $100,000,000


      Series B


      09/06/2018


      4D Molecular Therapeutics


      CA


      $90,000,000


      Series B


      08/01/2018


      Apeel Sciences


      CA


      $70,000,000


      


      02/02/2018


      Moderna Therapeutics


      MA


      $500,000,000


      


     

    Portfolio companies include:

     

    Recent News: